ESR1 and breast cancer: We hypothesized that the aCGH patterns resembling BRCA1- or 2-mutated breast cancers (BRCA-likeCGH status) would identify a subgroup of not only TN, but also ER-positive, HER2-negative breast cancer patients with tumors exquisitely sensitive to DNA DSB-inducing agents.